Register entry

NuCarePharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: ANDA 4.

Dosage formNDCs
tablet2
capsule, delayed release1
tablet, film coated1
RouteNDCs
oral4
Labeller name on the listingNDCs
nucarepharmaceuticals, inc.4
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
EszopicloneEszopiclonetablet, film coated, oral68071-3376ANDA
Levothyroxine SodiumLevothyroxine Sodiumtablet, oral68071-3692ANDA
Lisinopril and hydrochlorothiazideLisinopril and hydrochlorothiazidetablet, oral68071-3008ANDA
OmeprazoleOmeprazolecapsule, delayed release, oral68071-2199ANDA
Compare

Other companies listing eszopiclone

Enquiry

Common questions

Is NuCarePharmaceuticals, Inc. FDA approved?
NuCarePharmaceuticals, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does NuCarePharmaceuticals, Inc. make?
4 products are listed under NuCarePharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet; capsule, delayed release; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.